Stefano Cairo

Dr. Stefano Cairo

XenTech, Évry, France
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
ARAlexandre Reymond
Alexandre Reymond
GMGermana Meroni
Germana Meroni
AFAnna Fantozzi
Anna Fantozzi
Giuseppe MerlaGiuseppe Merla
Giuseppe Merla
SCStefano Cairo
Stefano Cairo
ABAndrea Ballabio
Andrea Ballabio

1 December 2008 in Cancer Cell
Verified
Journal Article
Closed access
SCStefano Cairo
Stefano Cairo
CACarolina Armengol
Carolina Armengol
ARAurélien De Reyniès
Aurélien De Reyniès
YWYu Wei
Yu Wei
ETEmilie Thomas
Emilie Thomas
MBMarie-Annick Buendia
Marie-Annick Buendia

3 May 2010 in Genome Research
Verified
Journal Article
Open access
PDF file
Stefano VoliniaStefano Volinia
Stefano Volinia
MGMarco Galasso
Marco Galasso
SCStefan Costinean
Stefan Costinean
LTLuca Tagliavini
Luca Tagliavini
GGGiacomo Gamberoni
Giacomo Gamberoni
CCCarlo Crocecarlo
Carlo Crocecarlo
We studied miRNA profiles in 4419 human samples (3312 neoplastic, 1107 nonmalignant), corresponding to 50 normal tissues and 51 cancer types. The complexity of our database enabled us to perform a detailed analysis of microRNA (miRNA) activities. We inferred genetic networks from miRNA expression in normal tissues and cancer. We also built, for the first time, specialized miRNA networks for solid tumors and leukemias. Nonmalignant tissues and cancer networks displayed a change in hubs, the most connected miRNAs. hsa-miR-103/106 were downgraded in cancer, whereas hsa-miR-30 became most prominent. Cancer networks appeared as built from disjointed subnetworks, as opposed to normal tissues. A comparison of these nets allowed us to identify key miRNA cliques in cancer. We also investigated miRNA copy number alterations in 744 cancer samples, at a resolution of 150 kb. Members of miRNA families should be similarly deleted or amplified, since they repress the same cellular targets and are thus expected to have similar impacts on oncogenesis. We correctly identified hsa-miR-17/92 family as amplified and the hsa-miR-143/145 cluster as deleted. Other miRNAs, such as hsa-miR-30 and hsa-miR-204, were found to be physically altered at the DNA copy number level as well. By combining differential expression, genetic networks, and DNA copy number alterations, we confirmed, or discovered, miRNAs with comprehensive roles in cancer. Finally, we experimentally validated the miRNA network with acute lymphocytic leukemia originated in Mir155 transgenic mice. Most of miRNAs deregulated in these transgenic mice were located close to hsa-miR-155 in the cancer network.

1 August 2008 in BMC Ecology and Evolution
Verified
Journal Article
Open access
PDF file
MSMarco Sardiello
Marco Sardiello
SCStefano Cairo
Stefano Cairo
BFBianca Fontanella
Bianca Fontanella
ABAndrea Ballabio
Andrea Ballabio
GMGermana Meroni
Germana Meroni
Background: The TRIM family is composed of multi-domain proteins that display the Tripartite Motif (RING, B-box and Coiled-coil) that can be associated with a C-terminal domain. TRIM genes are involved in ubiquitylation and are implicated in a variety of human pathologies, from Mendelian inherited disorders to cancer, and are also involved in cellular response to viral infection.Results: Here we defined the entire human TRIM family and also identified the TRIM sets of other vertebrate (mouse, rat, dog, cow, chicken, tetraodon, and zebrafish) and invertebrate species (fruitfly, worm, and ciona). By means of comparative analyses we found that, after assembly of the tripartite motif in an early metazoan ancestor, few types of C-terminal domains have been associated with this module during evolution and that an important increase in TRIM number occurred in vertebrate species concomitantly with the addition of the SPRY domain. We showed that the human TRIM family is split into two groups that differ in domain structure, genomic organization and evolutionary properties. Group 1 members present a variety of C-terminal domains, are highly conserved among vertebrate species, and are represented in invertebrates. Conversely, group 2 is absent in invertebrates, is characterized by the presence of a C-terminal SPRY domain and presents unique sets of genes in each mammal examined. The generation of independent sets of group 2 genes is also evident in the other vertebrate species. Comparing the murine and human TRIM sets, we found that group 1 and 2 genes evolve at different speeds and are subject to different selective pressures.Conclusion: We found that the TRIM family is composed of two groups of genes with distinct evolutionary properties. Group 2 is younger, highly dynamic, and might act as areservoirto develop novel TRIM functions. Since some group 2 genes are implicated in innate immune response, their evolutionary features may account for species-specific battles against viral infection.

1 December 2014 in Journal of Hepatology
Verified
Journal Article
Closed access
MEMelanie Eichenmüller
Melanie Eichenmüller
FTFranziska Trippel
Franziska Trippel
MKMichaela Kreuder
Michaela Kreuder
ABAlexander Beck
Alexander Beck
TSThomas Schwarzmayr
Thomas Schwarzmayr
Roland KapplerRoland Kappler
Roland Kappler

1 May 2010 in Cancer Cell
Verified
Journal Article
Closed access
KBKira Bettermann
Kira Bettermann
MVMihael Vucur
Mihael Vucur
JHJohannes Haybaeck
Johannes Haybaeck
CKChristiane Koppe
Christiane Koppe
JJJörn Janssen
Jörn Janssen
TLTom Luedde
Tom Luedde